Crucial role of JUN protein in restraining liver cancer growth discovered

by Leibniz Institute on Aging – Fritz Lipmann Institute (FLI)Synopsis. Credit:The EMBO Journal(2024). DOI: 10.1038/s44318-024-00188-0A team of scientists led by Dr. Björn von Eyss has disc

Updated on: September 07,2024 0

Crucial role of JUN protein in restraining liver cancer growth discovered

by Leibniz Institute on Aging – Fritz Lipmann Institute (FLI)Synopsis. Credit:The EMBO Journal(2024). DOI: 10.1038/s44318-024-00188-0A team of scientists led by Dr. Björn von Eyss has disc

Updated on:September 07,2024 0

Novel therapy studied for inherited breast cancer

by Will Sansom,University of Texas Health Science Center at San AntonioCredit: CC0 Public DomainUT Health San Antonio researchers have discovered a novel way to kill cancers that are caused by a

Updated on: May 27,2024 6

Novel therapy studied for inherited breast cancer

by Will Sansom,University of Texas Health Science Center at San AntonioCredit: CC0 Public DomainUT Health San Antonio researchers have discovered a novel way to kill cancers that are caused by a

Updated on:May 27,2024 6

First-line pembrolizumab plus chemotherapy may benefit patients with advanced biliary tract cancers

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untrea

Updated on: January 30,2024 19

First-line pembrolizumab plus chemotherapy may benefit patients with advanced biliary tract cancers

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainThe addition of pembrolizumab (Keytruda) to gemcitabine and cisplatin improved overall survival in patients with untrea

Updated on:January 30,2024 19

Adcetris FDA approval expanded to include later-stage Hodgkin's

(HealthDay)—U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin's lymphoma, the agency

Updated on: March 30,2024 19

Adcetris FDA approval expanded to include later-stage Hodgkin's

(HealthDay)—U.S. Food and Drug Administration approval of Adcetris (brentuximab vedotin) has been expanded to include adults with untreated stage III or IV classical Hodgkin's lymphoma, the agency

Updated on:March 30,2024 19

Arthritis linked to blood cancer mutations

by South Australian Health and Medical Research Institute (SAHMRI)Credit: Pixabay/CC0 Public DomainA team of Adelaide and U.S. researchers has discovered a link between a less common form of rheumatoi

Updated on: April 28,2024 0

Arthritis linked to blood cancer mutations

by South Australian Health and Medical Research Institute (SAHMRI)Credit: Pixabay/CC0 Public DomainA team of Adelaide and U.S. researchers has discovered a link between a less common form of rheumatoi

Updated on:April 28,2024 0

Researchers develop comprehensive new way to predict breast cancer risk

by Cancer Research UKThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom Misteli,

Updated on: June 08,2024 3

Researchers develop comprehensive new way to predict breast cancer risk

by Cancer Research UKThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Image created in 2014 by Tom Misteli,

Updated on:June 08,2024 3

Potential therapeutic target for small cell lung cancer discovered

by Melissa Rohman,Northwestern UniversityGraphic model showing how POU2AF2 establishes the poised enhancer via SWI/SNF activity-dependent recruitment of the Polycomb complex in SCLC-P subtype ce

Updated on: April 28,2024 0

Potential therapeutic target for small cell lung cancer discovered

by Melissa Rohman,Northwestern UniversityGraphic model showing how POU2AF2 establishes the poised enhancer via SWI/SNF activity-dependent recruitment of the Polycomb complex in SCLC-P subtype ce

Updated on:April 28,2024 0

DDX41 and its unique contribution to myeloid leukemogenesis

by Impact Journals LLCCredit: Unsplash/CC0 Public DomainIn an editorial paper published inOncotargettitled, "DDX41 and its unique contribution to myeloid leukemogenesis," researc

Updated on: August 03,2024 0

DDX41 and its unique contribution to myeloid leukemogenesis

by Impact Journals LLCCredit: Unsplash/CC0 Public DomainIn an editorial paper published inOncotargettitled, "DDX41 and its unique contribution to myeloid leukemogenesis," researc

Updated on:August 03,2024 0

Zika virus could help combat brain cancer

by FAPESPStudy by Brazilian researchers shows infection by Zika caused death of cells from glioblastoma, the most common and aggressive kind of malignant brain tumor in adults . Credit: cytopathi

Updated on: March 01,2024 18

Zika virus could help combat brain cancer

by FAPESPStudy by Brazilian researchers shows infection by Zika caused death of cells from glioblastoma, the most common and aggressive kind of malignant brain tumor in adults . Credit: cytopathi

Updated on:March 01,2024 18

Two for the price of one: Mechanistic insights lead to drug repositioning

by University of TsukubaMolecular mechanism at a glance. SFN binds with SKP1 to sequester it in cytoplasm,resulting in the obstruction of SCFFBW7 598 complex formation. Oncoproteins including cyc

Updated on: May 23,2024 5

Two for the price of one: Mechanistic insights lead to drug repositioning

by University of TsukubaMolecular mechanism at a glance. SFN binds with SKP1 to sequester it in cytoplasm,resulting in the obstruction of SCFFBW7 598 complex formation. Oncoproteins including cyc

Updated on:May 23,2024 5

Long-term collection of patient-reported outcome data in oncology trials: Important and feasible

by Institute for Quality and Efficiency in Health CareCredit: CC0 Public DomainPatient-reported outcome (PRO) data are collected in oncology trials to determine patients' perspectives of canc

Updated on: January 30,2024 10

Long-term collection of patient-reported outcome data in oncology trials: Important and feasible

by Institute for Quality and Efficiency in Health CareCredit: CC0 Public DomainPatient-reported outcome (PRO) data are collected in oncology trials to determine patients' perspectives of canc

Updated on:January 30,2024 10

Stress-tolerant cells shown to drive tumor initiation in pancreatic cancer

by University of California - San DiegoTumor-initiating cells (blue) produce an extracellular matrix containing fibronectin (pink) which gives them increased stress tolerance, drug resistance and

Updated on: February 23,2024 16

Stress-tolerant cells shown to drive tumor initiation in pancreatic cancer

by University of California - San DiegoTumor-initiating cells (blue) produce an extracellular matrix containing fibronectin (pink) which gives them increased stress tolerance, drug resistance and

Updated on:February 23,2024 16